The Scientist

» infectious disease and neuroscience

Most Recent

image: Ebola Victims Still Infectious a Week After Death

Ebola Victims Still Infectious a Week After Death

By | February 12, 2015

Ebola virus can remain infectious for up to seven days on the bodies of monkeys that died from the disease, researchers show.

0 Comments

image: Smartphone Diagnostic

Smartphone Diagnostic

By | February 5, 2015

Researchers design a device that attaches to a smartphone to test for diverse infectious diseases from a drop of blood.

0 Comments

image: “Inner GPS” Support

“Inner GPS” Support

By | February 5, 2015

Grid cells—the neurons that function as a spatial navigation system—require input from another set of neurons, a rat study shows.

2 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Bouncing Back

Bouncing Back

By | February 1, 2015

In mice, a transcriptional regulator, β-catenin, activates a microRNA-processing pathway in the nucleus accumbens to promote resilience to social stress.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | February 1, 2015

Touch, The Altruistic Brain, Is Shame Necessary?, and Future Arctic

0 Comments

image: Centennial <em>Shigella</em>

Centennial Shigella

By | February 1, 2015

A strain of the dysentery-causing bacterium isolated in 1915 tells the story of a young soldier who died of the disease in the early days of World War I.

0 Comments

image: Facing Down Emerging Viruses

Facing Down Emerging Viruses

By | February 1, 2015

A better knowledge of the pathogenesis of emerging zoonotic diseases is crucial if we want to prepare for “the next Ebola.”

0 Comments

image: Viral Virtuosos

Viral Virtuosos

By | February 1, 2015

New understanding of noncoding RNAs may solve a long-standing puzzle about how viruses orchestrate lifelong infections.  

3 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS